Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

导出原文传递

翻译打印收藏纠错

作者： Adkins, Douglas ^[1] ; Ley, Jessica ^[2] ; Neupane, Prakash ^[3] ; Worden, Francis ^[4] ; Sacco, Assuntina G. ^[5] ; Palka, Kevin ^[6] ; Grilley-Olson, Juneko E. ^[7] ; Maggiore, Ronald ^[8] ; Salama, Noha N. ^[9] ; Trinkaus, Kathryn ; Van Tine, Brian A. ; Steuer, Conor E. ; Saba, Nabil F. ; Oppelt, Peter

作者单位： Washington Univ, Sch Med, Biostat Shared Resource, St Louis, MO 63110 USA ^[1] Univ Rochester, Dept Med, Wilmont Canc Inst, Rochester, NY USA ^[2] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt ^[3] Univ Kansas, Sch Med, Div Oncol, Kansas City, KS USA ^[4] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA ^[5] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA ^[6] Univ N Carolina, Sch Med, Dept Med, Div Hematol Oncol, Chapel Hill, NC 27515 USA ^[7] Washington Univ, Sch Med, Div Med Oncol, St Louis, MO 63110 USA ^[8] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA ^[9]

发布时间 2020-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The lancet oncology

2019年20卷9期

1295-1305页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

The lancet oncology

相似文献

The lancet oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

The lancet oncology

相似文献

The lancet oncology

相关期刊

检索历史清除